These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38578333)

  • 1. Changes in intraocular pressure following intravitreal dexamethasone implant in patients with history of glaucoma filtration surgery.
    Lee DK; Lee JY; Woo SJ; Ji YS; Lee CS
    Graefes Arch Clin Exp Ophthalmol; 2024 Sep; 262(9):2845-2850. PubMed ID: 38578333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
    Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.
    Malclès A; Dot C; Voirin N; Vié AL; Agard É; Bellocq D; Denis P; Kodjikian L
    Retina; 2017 Jul; 37(7):1352-1359. PubMed ID: 27768641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma.
    Nguyen T; Kim H; Mielke C; Momont AC; Brandt JD; Liu Y
    J Glaucoma; 2020 Apr; 29(4):252-257. PubMed ID: 31990825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
    Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
    Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.
    Hemarat K; Kemmer JD; Porco TC; Eaton AM; Khurana RN; Stewart JM
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):680-685. PubMed ID: 30222802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION.
    Sudhalkar A; Kodjikian L; Chhablani J; Bhojwani D; Vasavada A
    Retina; 2018 Dec; 38(12):2343-2349. PubMed ID: 29016454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
    Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
    Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study.
    Sweta VD; Shibi Dev BN; Sandhya R
    Indian J Ophthalmol; 2022 Feb; 70(2):585-589. PubMed ID: 35086242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS.
    Srinivasan R; Sharma U; George R; Raman R; Sharma T;
    Retina; 2019 Jan; 39(1):157-162. PubMed ID: 29095355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.
    Meyer LM; Schönfeld CL
    J Ocul Pharmacol Ther; 2013; 29(6):560-5. PubMed ID: 23480270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
    Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
    Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
    Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
    Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
    Chin EK; Almeida DRP; Velez G; Xu K; Peraire M; Corbella M; Elshatory YM; Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
    Retina; 2017 Jul; 37(7):1345-1351. PubMed ID: 27806001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.
    Mazzarella S; Mateo C; Freixes S; Burés-Jelstrup A; Rios J; Navarro R; García-Arumí J; Corcóstegui B; Arrondo E
    Ophthalmic Res; 2015; 54(3):143-9. PubMed ID: 26394206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience.
    Ozkaya A; Alagoz C; Alagoz N; Gunes H; Yilmaz I; Perente I; Yazici AT; Taskapili M
    Eur J Ophthalmol; 2016 Jun; 26(4):351-5. PubMed ID: 26692061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Ahmed glaucoma valve implantation for steroid-induced elevated intraocular pressure in patients with retinitis pigmentosa.
    Eksioglu U; Oktem C; Sungur G; Yakin M; Demirok G; Ornek F
    Int Ophthalmol; 2018 Oct; 38(5):1833-1838. PubMed ID: 28733929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.